Renaissance Capital logo

Proteon Therapeutics Priced, Nasdaq: PRTO

Developing a treatment to reduce failure rates of a dialysis-related procedure.

Industry: Health Care

First Day Return: +0.3%

Industry: Health Care

Developing a treatment to reduce failure rates of a dialysis-related procedure.
more less

Proteon Therapeutics (PRTO) Performance